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Available online 20 March 2020Introduction:Mood disorder is common in cervical dystonia, affects quality of life andmay precede the onset of the dys-
tonia. There is controversy as to whether mood disorder is part of the primary process or secondary to the disability.
We assessed the characteristics of cervical dystonia patients in relation to a past history of mood disorder.
Methods: At a University Hospital clinic, in all consenting patients with cervical dystonia, we uniformly collected de-
mographic data, medical history, and prospectively, measures of prevalent mood disorder.
Results: In 193 patients (128women and 65men)mean age at onset was 43.9 years andmean duration of cervical dys-
tonia was 17.5 years. Men had earlier age at onset of cervical dystonia than women (p= 0.0037). A history of a mood
disorder was reported in 53/128 (41%) women with a significantly earlier median age at onset of cervical dystonia
(42 years) than 75/128 (59%) women with no history of mood disorder (48 years) (p = 0.005); 33 (26%) women
with mood disorder prior to dystonia also had an earlier age at onset of dystonia than the 75 without such a history
(p = 0.0154). A history of mood disorder was more common in women (41%) than men (31%); 54/128 (42%)
women and 21/65 (32%) men had current mood disorder symptoms.
Conclusions: In our cervical dystonia clinic population significant differences in the age at onset in women with, and
without, a history of mood disorder strongly indicates that anxiety and depression are primary non-motor (and






Dystonia is amovement disorder characterized by sustained or intermit-
tent muscle contractions causing abnormal, often repetitive, movements
and postures [1]. Focal isolated dystonia, affecting muscles in a particular
anatomical distribution, with or without tremor, and no other neurological
signs, is the most common type of adult-onset dystonia. Cervical dystonia is
the most prevalent form of adult onset dystonia worldwide; both its
aetiology and pathogenesis are poorly understood. Psychiatric symptoms,
especially anxiety and depression, are commonly observed occurring in
30–60% of cervical dystonia patients [2–13].
There is debate as towhether themooddisorder is secondary to the stigma
of a socially obvious movement disorder or is a primary symptom, caused by
the same disordered neurobiological processes driving the abnormal move-
ments. In support of the latter concept, it has been observed that depression
and/or anxiety may precede the onset of the dystonic motor symptoms,
often by many years [13]. In this study, we assessed the history of, andom Dystonia Ireland, the Health
roscience Foundation (no grant
incent's University Hospital, Elm
we).
r Ltd. This is an open access articleprevalence of, mood disorder of patients attending a single-center, tertiary
hospital with cervical dystonia in relation to their demographic variables.
2. Methods
2.1. Study participants
The study participants were recruited from a database of dystonia pa-
tients attending the botulinum toxin clinic at a single tertiary hospital,
where>60%of the clinically diagnosed cervical dystonia patients in the Re-
public of Ireland are treated [14] from July 2018 to April 2019. We con-
ducted a cross-sectional study of all consenting patients with adult-onset
cervical dystonia, diagnosed by two experienced movement disorders neu-
rologists according to the standard diagnostic criteria [1]. We excluded pa-
tients with other forms of dystonia including, generalized dystonia,
segmental disorder and other focal dystonias, other neurological disorders
and other comorbidities (cognitive impairment) which precluded comple-
tion of questionnaires utilized in this study.
2.2. Assessment instruments
Using a questionnaire designed specifically for our study, we collected
basic demographic information from our patients including age at the
time of study, age at onset of cervical dystonia, duration of cervicalunder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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any medical practitioner), time of onset of anxiety or depression relative
to onset of cervical dystonia and other medical background history. We
used the revised Toronto Western Spasmodic Torticollis Ratings Scale – 2
Pain (TWSTRS-2 Pain) and the pain subscale of the Cervical Dystonia Im-
pact Profile – 58 (CDIP-58) to assess pain;. These questionnaires are all val-
idated rating scales with high reliability for use in both clinical and non-
clinical settings [15]. We used the Beck Anxiety Inventory (BAI) and Beck
Depression Inventory, second edition (BDI-II) to assess current anxiety
and/or depression symptoms. The BAI and BDI-II are both 21-item self-
report assessment tools for anxiety and depression respectively. They are
each rated on a 4-point scale from 0 to 3 with a maximum total score of
63 each [16–21]. The patients were recruited on the day of their scheduled
appointment for botulinum toxin injection. For the TWSTRS-2 Pain scale,
CDIP-58, BAI and BDI, the patients were required to fill these question-
naires within one week of receiving their botulinum toxin injection and
the questionnaires referred to symptoms in the last 2 weeks at the time of
filling out the questionnaire. This reflects the period at which the botuli-
num toxin effect has worn off or is minimal. When a questionnaire was in-
correctly/incompletely filled out, the patient was contacted again at their
next 3-monthly appointment for botulinum toxin injection. The majority
of the patients filled out all their questionnaires on the day they were re-
cruited, others took them home and posted them back within the one
week advised. As the study period was from July 2018 to April 2019 with
patients attending for botulinum toxin injection 3-monthly, patients who
failed to correctly/completely fill out their questionnaires after 4 attempts
at recruitment were not included.
2.3. Statistical analysis
We tested our variables for normality and lognormality using Anderson-
Darling, D'Agostino & Pearson, Shapiro-Wilk, and Kolmogorov-Smirnov
tests. The Anderson-Darling and Komogorov-Smirnov tests showed a nor-
mal distribution for only the age at time of study and age at onset variable.
Given the non-Gaussian distribution of our data we used non-parametric
tests for analysis.Means with standard deviation, medians and interquartile
range (IQR) were used to describe the distribution of our data set. We used
the Mann-Whitney (M-W) test to compare the differences between two in-
dependent groups with dependent variables. Significance level was defined
as p < 0.05.
2.4. Study protocols
The study was reviewed and approved by the St Vincent's Healthcare
Group Ethics and Medical Research Committee. All participants gave writ-
ten informed consent prior to their participation in the study.
3. Results
3.1. Study cohort characteristics
213 cervical dystonia patients fulfilled our study criteria; two patients
did not consent to participate in the study and 18, who did not fully com-
plete the questionnaires, were excluded, leaving 193 for analysis
(Table 1). The 193 patients {128 (66%) women and 65 (34%) men} had
a mean age (±Standard Deviation) of 61.7 (±13.0) years; mean age at
onset of cervical dystonia was 43.9 (±12.9) years, mean duration of cervi-
cal dystonia was 17.5 (±11.7) years, mean TWSTRS-2 Pain was 13.57 (±
9.8) and mean Pain subscale of CDIP-58 was 45.22 (±30.47) (Table 1).
3.2. Sex and age at onset of cervical dystonia
The 65 men had a significantly earlier age of onset of cervical dystonia
than the 128 women (Fig. 1){Men's age at onset: mean 40.0 ± 12.0 years;
median 41.0 years (IQR 28.5–50). Women's age at onset: mean 45.9 ±2
12.7 years; median 46 years (IQR 36.5–55.8); p = 0.0037 (M-W U =
3100) (Table 1)}.
3.3. History of anxiety or depression and age at onset of cervical dystonia
Although commoner in women, there was no significant sex difference
in the frequencies of a history of anxiety or depression, both before and
after the onset of motor symptoms of cervical dystonia. Of the 128
women, 53 (41%) reported a medical history of anxiety and/or depression;
33 (26%) had onset of mood disorder prior to the development of cervical
dystonia (median duration prior: 10.0 years; IQR: 5–17 years). Of the 65
men, 21 (32%) reported a history of anxiety and/or depression with 11
(17%) prior to the onset of cervical dystonia (median duration prior:
2.0 years; IQR: 2–15 years).
The 53 women with a history of anxiety and/or depression at any time
had significantly earlier age at onset of cervical dystonia (Mean: 42.3 ±
11.7 years;Median 42 years, IQR=32–50) than the 75womenwith nohis-
tory of mood disorder {Mean: 48.5± 12.8 years; Median: 48 years, IQR=
41–58; (p = 0.005; M-W U = 1412)} (Table 1 & Fig. 2).
In 21men with history of anxiety and/or depression, the age at onset of
cervical dystonia was non-significantly earlier {Mean: 38.8 ± 13.1 years;
Median: 39 years (IQR= 26.5–51)} than the age at onset in 44 men with-
out a history of anxiety and/or depression {Mean: 40.4 ± 12.0 years; Me-
dian: 42 years (IQR = 30–50.8) (p = 0.613; M-W U = 425.5)}.
3.4. History of anxiety or depression prior to onset of cervical dystonia and age at
onset
We further compared the age at onset between 33womenwith a history
of anxiety and/or depression preceding the onset of cervical dystonia and
75 women without any history of anxiety and/or depression; 33 women
with mood disorder preceding the onset of cervical dystonia had a signifi-
cantly earlier onset of dystonia than the 75 women with no history of
mood disorder {Mean: 42.5 ± 10.7; Median: 42 (IQR 32.5–50.0) and
Mean 48.5 ± 12.8; Median: 48.0 (IQR 41.0–58.0) respectively. p =
0.0154 (M-W U 876)}.
3.5. No history of anxiety or depression and age at onset of cervical dystonia
There were 44/65 (68%) men and 75/128 (59%) women with no med-
ical history of depression or anxiety. The 44 men had a significantly earlier
age at onset of cervical dystonia than the 75 women {Men's age at onset:
mean 40.4 ± 12.0 years; median 42 years (IQR 30–50.8). Women's age
at onset: mean 48.5 ± 12.8 years; median 48 years (IQR 41–58), p =
0.0014 (M-W U = 1075)}.
3.6. Current anxiety/depression symptoms & age at onset of cervical dystonia
Using the BAI and BDI-II, with scores >13 for each assessment tool
representing evidence of anxiety or depression symptoms, 54/128 (42%)
women and 21/65 (32%) men reported current anxiety and/or depression
symptoms. The age at onset of 54 women with current anxiety and/or de-
pression symptoms (mean=44.1±11.8 years; median: 43 years; IQR 33–
52.3) was non-significantly earlier than the 74womenwithout current anx-
iety and/or depression (Mean: 47.3 ± 13.2 years; median: 48 years, IQR
40–56.3) (p = 0.1062; M-W U = 1663. Similarly, the age at onset of 21
men with current mood disorder was non-significantly earlier than the 44
men without current anxiety/depression {Mean: 38.8 ± 13.1 years; me-
dian: 39 years, IQR 26.5–51, and mean: 40.0 ± 12.0 years; median:
42 years, IQR 30–50 respectively (p = 0.694, M-W U = 423.5)}.
Of the 74/128 (58%) women and 44/65 (68%) men who scored ≤13
on the BAI and BDI, indicating no current anxiety or depressive symptoms;
19/74 (26%) women and 8/44 (18%) men reported a history of medically
diagnosed anxiety and/or depression.
Table 1












































































































































Age at onset of cervical dystonia and duration of illness in years (y) in 193 cervical dystonia patients, with mean (±SD) and median {with interquartile ranges (IQR)} with
Mann-Whitney (M-W) comparisons and level of significance. There were 128/193 (66%) women and 65/193 (34%) men; both women and men were subdivided according
to a reported history of mood disorder. All men had a significantly earlier age at onset of cervical dystonia than all women. Women with a history of mood disorder had a
significantly earlier onset than women with no such history. No significant difference was found in the ages at onset of men with, and without, a history of mood disorder.
All women had a significantly worse CDIP-58 Pain subscale scores than all women.
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There was a significant difference between 128 women and 65 men in
their CDIP-58 Pain subscale scores with women having worse pain scoresFig. 1. Cumulative percentage affected by age at onset of cervical dystonia for 65/
193 men (blue squares and connecting lines) and 128/193 women (red circles and
connecting line). The 65 men had median age at onset of CD of 41 years; the 128
women had median age at onset of CD of 46 years (P = 0.0037; Mann-Whitney;
see Table 1). (For interpretation of the references to colour in this figure legend,
the reader is referred to the web version of this article.)
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{Mean: 48.69 ± 27.7; Median: 58 (IQR 0–100) and Mean 39.69 ±
27.69; Median: 37.5 (IQR 0–100) respectively. p = 0.0431 (M-W U
3278)} but there was no significant difference between 128 women and
65men in their TWSTRS-2 Pain scores {Women - Mean: 14.64±10.2; Me-
dian: 14 (IQR 0–42) andMen - Mean 11.74±8.18; Median: 13 (IQR 0–37)
respectively. p = 0.0794 (M-W U 3373)}. There was no significant differ-
ence in CDIP-58 Pain subscale scores and TWSTRS-2 Pain score when the
53 women with a history of anxiety and/or depression were compared to
the 75 women without a history of anxiety and/or depression. This was
also similar when 21 men with a history of anxiety and/or depression
were compared to 44 men without a history of anxiety and/or depression
(Table 1).
3.6.2. Other comorbidities and marital status
There were no significant differences in the prevalence of co-
morbidities between CD patients with and without a history of mood disor-
der (Table 2). The most prevalent medical diagnosis was hypertension; this
was similar across all 3 subgroups (16% in all participants, 20% in the par-
ticipants with a history of mood disorder at any time, 12.6% in the group
without mood disorder and 16% in the group with a history of mood disor-
der preceding the onset of CD. Other comorbidities included hypercholes-
terolemia, hypothyroidism, asthma/chronic obstructive pulmonary
disease (COPD), gastro-oesophageal reflux disease, atrialfibrillation, arthri-
tis, diabetes mellitus II, epilepsy, overactive bladder, myocardial infarction,
peripheral vascular disease and breast cancer in remission. Amongst the
participants with mood disorder, none had asthma/COPD, atrial fibrilla-
tion, over active bladder, myocardial infarction or breast cancer.
Marital status was similar across all groups except in the group with a
history of mood disorder who reported 12% separated; this was twice
more common than the groupwithout a history of mood disorder, although
still relatively low (Table 2).
Table 2

























Other comorbidities excluding mood disorder
None 128 (66%) 45 (60.8%) 83 (69.7%) 28 (63.6%)
Hypertension 30 (15.5%) 15 (20.3%) 15 (12.6%) 7 (15.9%)
Hypercholesterolemia 22 (11.4%) 12 (16.2%) 10 (8.4%) 6 (13.6%)
Hypothyroidism 14 (7.3%) 6 (8.1%) 8 (6.7%) 1 (2.3%)
Asthma/COPD 5 (2.6%) 0 5 (4.2%) 0
Gastro-oesophageal
reflux disease
4 (2.1%) 1 (1.4%) 3 (2.5%) 1 (2.3%)
Atrial fibrillation 4 (2.1%) 0 4 (3.4%) 0
Gout/Arthritis 4 (2.1%) 2 (2.7%) 2 (1.7%) 0
Diabetes Mellitus II 2 (1%) 1 (1.4%) 1 (0.8%) 1 (2.3%)
Epilepsy 1 (0.52%) 1 (1.4%) 0 0
Overactive bladder 1 (0.52%) 0 1 (0.8%) 0
Myocardial Infarction 1 (0.53%) 0 1 (0.8%) 0
Peripheral vascular
disease
1 (0.52%) 1 (1.4%) 0 0
Breast cancer in
remission
1 (0.52%) 0 1 (0.8%) 0
Marital status
Married 110 (57%) 38 (51.4%) 72 (60.5%) 21 (47.7%)
Single 43 (22.3%) 17 (23%) 26 (21.8%) 9 (20.5%)
Widow(er) 19 (9.84%) 6 (8%) 13 (10.9%) 4 (9.1%)
Separated 13 (6.74%) 9 (12.2%) 4 (3.4%) 7 (15.9%)
Divorced 8 (4.12%) 4 (5.4%) 4 (3.4%) 3 (6.8%)
Comorbidities and marital status presented as number of patients and percentage
for the entire study cohort and also in groups including, group with history of
mood disorder at anytime, the groupwithout a history ofmood disorder, the groups
with a history of mood disorder preceding the onset of CD and the participants alto-
gether. The comorbidities and marital status were similar across all groups.
Fig. 2. Cumulative percentage affected by age at onset of cervical dystonia for 53/
128 women with a history of mood disorder (blue triangles and connecting line)
and 75/128 women with no history of a mood disorder (red circles and
connecting line). The 53 women with mood disorder history had a median age at
onset of CD of 42 years; the 75 women with no such history had a median age at
onset of CD of 48 years (p = 0.005; Mann-Whitney; see Table 1). (For
interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
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In this comprehensive, single-center survey of patients with adult-onset
cervical dystonia we found that men had significantly earlier age at onset of
cervical dystonia than women; this has been previously reported [22,23].
Men not reporting a medical history of depression or anxiety also had a sig-
nificantly earlier age at onset than women without a history of mood
disorder.
The most important, novel, observation in this study is that women
reporting a history of anxiety and/or depression, at any stage, had a signif-
icantly earlier age at onset of cervical dystonia than women not reporting
anxiety and/or depression.We also found thatwomenwith a history of anx-
iety and/or depression preceding the onset of motor symptoms had a signif-
icantly earlier age at onset of cervical dystonia, when compared to women
without any history of mood disorder.
In the case of men, while those reporting a history of anxiety and/or de-
pression also had earlier age at onset of cervical dystonia, when compared
to men without such a history, this difference was not statistically signifi-
cant. The latter, non-significant finding, may be a Type-2 error, given the
relatively smaller numbers of male cervical dystonia patients in our study
cohort.
One possible explanation of the effect of preceding mood disorder and
earlier age at onset of motor symptoms might be that patients, reporting a
history mood disorder, are more likely to be under medical surveillance
and thus their dystonia might be more quickly diagnosed. We consider
this is an unlikely explanation, given the six-year difference in reportedme-
dian ages of onset in the two groups of women (with and without mood
disorder).
Ourfindings also confirm the accumulating evidence of the co-existence
of anxiety and depression with cervical dystonia [2–13]. In our study, 41%
of women and 32% of men (38.3% of all 193 participants) reported a past
history of anxiety and/or depression, which preceded motor symptoms in
26% women & 17% of men. Current anxiety and/or depression symptoms
(by the BAI and BDI-II) were, non-significantly, more common in women
(43% women and 36% men). Patients with current anxiety and/or depres-
sion symptoms, as shown by the BAI& BDI-II, had an earlier age at onset of4
cervical dystonia when compared with those without, but this was not sta-
tistically significant. A possible explanation for this is that, while BAI&BDI-
II are reliable and validated assessment tools for assessing anxiety and de-
pression [16–21], they were designed as screening rather than diagnostic
tools, reporting the extent to which patient has anxiety and depressive
symptoms in “the week preceding” their completion of the questionnaires
[24–26]. Another limitation of BAI & BDI is that, in participants with con-
comitant physical illness, their reliance on symptoms such as fatigue, tin-
gling, etc., may artificially influence scores due to symptoms related to
the physical disorder, rather than due to mood disorder. In addition, of
the 118 patients who scored≤13 indicating no current anxiety and/or de-
pression symptoms, 27 patients (19 women and 8 men) had an established
history of medically diagnosed anxiety and/or depression. The normal
scores in these patients could probably be explained by an improvement
of anxiety and/or depressive symptoms due to the effectiveness of ongoing
treatment of the mood disorders. This is one of the intended uses of BAI &
BDI-II [24–26].
Pain was more prevalent in the group with a history of anxiety and/or
depression when compared to the group without. A possible explanation
for this could be that pain predisposed this group to anxiety and/or depres-
sion; another explanation is that CD patients with a clinical history of anx-
iety and/or depression may report more distress in relation to pain.
The strength of this study is that it comes from a large single University
Hospital with some patients attending for as long as 30 years. Given that
botulinum toxin is the most effective therapy for CD, this seemed to be
the most appropriate form of recruitment of this group of patients; we esti-
mate that we treat 60% of the cervical dystonia patient population in
Ireland and the overwhelming majority of patients had been seen within
two years after onset of CD symptoms. The limitations in the study include
a necessarily retrospective patient-report of the time of onset of mood dis-
order in relation to the onset of their cervical dystonia (but recorded in
I. Ndukwe et al. Clinical Parkinsonism & Related Disorders 3 (2020) 100049medical notes at the time of initial presentation) and the use of BAI& BDI as
measures of current mood disorder which do not distinguish between en-
dogenous and exogenous depression.
These findings indicate that both sex and mood disorder have indepen-
dent effects on age at onset of adult-onset cervical dystonia and support the
concept that mood disorder is a primary non-motor and premotor symptom
of cervical dystonia, reflecting disordered neurobiological mechanisms,
presumably affecting the limbic system [27]. Postulated pathophysiological
models of adult-onset isolated dystonia must consider these independent
factors, mood disorder and sex, in relation to age at onset, in any hypothet-
ical disordered network.
In conclusion, we have observed significant differences in the age at
onset in women with and without a history of mood disorder. We consider
this observation strongly indicates that anxiety and depression are primary
non-motor and premotor symptoms of cervical dystonia.
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